Hepatitis delta: On soft paws across Germany

Infection

Volumn 40, Issue 6, 2012, Pages 621-625

  Reinheimer, C ^a   Doerr, H W ^a   Berger, A ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Germany 2011; HDV; Hepatitis delta; Seroprevalence

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G; VIRUS ANTIBODY; VIRUS RNA;

ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CLINICAL EVALUATION; CONTROLLED STUDY; DELTA AGENT HEPATITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GERMANY; HEPATITIS DELTA VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; RNA ANALYSIS; SEROPREVALENCE; VIRUS LOAD;

COINFECTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GERMANY; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS; IMMUNOGLOBULIN G; MALE; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES;

EID: 84874117556     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-012-0287-9     Document Type: Article

References (33)

1. Rizzetto M, Canese MG, Aricò S, Crivelli O, Trepo C, Bonino F, Verme G. Immunofluorescence detection of new antigenantibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut. 1977;18:997-1003.
2. Rizzetto M, Hoyer B, Canese MG, Shih JW, Purcell RH, Gerin JL. Delta agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. Proc Natl Acad Sci USA. 1980;77:6124-8.
3. Rizzetto M. Hepatitis D: thirty years after. J Hepatol. 2009;50: 1043-50.
4. Rizzetto M. Hepatitis D: clinical features and therapy. Dig Dis. 2010;28:139-43.
5. Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet. 2011;378:73-85.
6. Farci P. Delta hepatitis: an update. J Hepatol. 2003;39:S212-9.
7. Hadziyannis SJ. Review: hepatitis delta. J Gastroenterol Hepatol. 1997;12:289-98.
8. Rizzetto M, Ponzetto A, Forzani I. Hepatitis delta virus as a global health problem. Vaccine. 1990;8:S10-4.
9. Wedemeyer H, Heidrich B, Manns MP. Hepatitis D virus infection- not a vanishing disease in Europe! Hepatology. 2007;45: 1331-2.
10. Thierfelder W, Hellenbrand W, Meisel H, Schreier E, Dortschy R. Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998. Eur J Epidemiol. 2001;17:429-35.
11. Epidemiologisches Bulletin Nr. 29. Berlin: Robert Koch-Instit; 2011.
12. Wu JC, Chen CM, Sheen IJ, Lee SD, Tzeng HM, Choo KB. Evidence of transmission of hepatitis D virus to spouses from sequence analysis of the viral genome. Hepatology. 1995;22: 1656-60.
13. Rizzetto M. Hepatitis D: clinical features and therapy. Dig Dis. 2010;28:139-43.
14. Wedemeyer H, Yurdaydìn C, Dalekos GN, Erhardt A, Çakaloǧlu Y, Deǧertekin H, Gürel S, Zeuzem S, Zachou K, Bozkaya H, Koch A, Bock T, Dienes HP, Manns MP; HIDIT Study Group. Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med. 2011;364:322-31.
15. Reinheimer C, Allwinn R, Doerr HW. Limited prevalence of influenza A/H1N1v antibodies: footprints of the pandemic of 2010. Infection. 2011;39:101-4.
16. Sakugawa H, Nakasone H, Nakayoshi T, Kawakami Y, Yamashiro T, Maeshiro T, Kinjo F, Saito A, Zukeran H. Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection. J Med Virol. 2001;65:478-84.
17. Yamashiro T, Nagayama K, Enomoto N, Watanabe H, Miyagi T, Nakasone H, Sakugawa H, Watanabe M. Quantitation of the level of hepatitis delta virus RNA in serum, by real-time polymerase chain reaction-and its possible correlation with the clinical stage of liver disease. J Infect Dis. 2004;189:1151-7.
18. Hadziyannis SJ, Sherman M, Lieberman HM, Shafritz DA. Liver disease activity and hepatitis B virus replication in chronic delta antigen-positive hepatitis B virus carriers. Hepatology. 1985;5: 544-7.
19. Mumtaz K, Ahmed US, Memon S, Khawaja A, Usmani MT, Moatter T, Hamid S, Jafri W. Virological and clinical characteristics of hepatitis delta virus in South Asia. Virol J. 2011; 8:312.
20. Fattovich G, Boscaro S, Noventa F, Pornaro E, Stenico D, Alberti A, Ruol A, Realdi G. Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B. J Infect Dis. 1987;155:931-5.
21. Weber B, Rabenau H, Berger A, Scheuermann EH, Staszewski S, Kreuz W, Scharrer I, Schoeppe W, Doerr HW. Seroprevalence of HCV, HAV, HBV, HDV, HCMV and HIV in high risk groups/Frankfurt a.M., Germany. Zentralbl Bakteriol. 1995;282:102-12.
22. Zaki H, Darmstadt GL, Baten A, Ahsan CR, Saha SK. Seroepidemiology of hepatitis B and delta virus infections in Bangladesh. J Trop Pediatr. 2003;49:371-4.
23. Viana S, Paraná R, Moreira RC, Compri AP, Macedo V. High prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon. Am J Trop Med Hyg. 2005;73: 808-14.
24. Erhardt A, Hoernke M, Heinzel-Pleines U, Sagir A, Göbel T, Häussinger D. Retrospective analysis of chronic hepatitis D in a West German University clinic over two decades: migratory pattern, prevalence and clinical outcome. Z Gastroenterol. 2010;48:813-7.
25. Langer BC, Frösner GG, von Brunn A. Epidemiological study of viral hepatitis types A, B, C, D and E among Inuits in West Greenland. J Viral Hepat. 1997;4:339-49.
26. Mohammad Alizadeh AH, Ranjbar M, Tehrani AS, Keramat F, Mamani M, Rezazadeh M, Aini P, Khalilian A, Majlesi A, Hajilooi M. Seroprevalence of hepatitis D virus and its risk factors in the west of Iran. J Microbiol Immunol Infect. 2010;43:519-23.
27. Kim HS, Kim SJ, Park HW, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea. J Med Virol. 2011;83:1172-7.
28. Inoue J, Takahashi M, Nishizawa T, Narantuya L, Sakuma M, Kagawa Y, Shimosegawa T, Okamoto H. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia. J Med Virol. 2005;76:333-40.
29. Shaikh MA, Shaikh WM, Solangi GA, Shaikh BA, Soomro MA. Frequency of hepatitis D virus infection in hepatitis B surface antigen-positive liver diseases. J Coll Physicians Surg Pak. 2011;21:23-5.
30. Roingeard P, Sankalé JL, Dubois F, Diouf A, Bacha A, Mboup S, Goudeau A. Infection due to hepatitis delta virus in Africa: report from Senegal and review. Clin Infect Dis. 1992;14:510-4.
31. Genné D, Rossi I. Hepatitis delta in Switzerland: a silent epidemic. Swiss Med Wkly. 2011;141:w13176.
32. Cross TJ, Rizzi P, Horner M, Jolly A, Hussain MJ, Smith HM, Vergani D, Harrison PM. The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol. 2008;80:277-82.
33. Yurdaydin C, Idilman R, Bozkaya H, Bozdayi AM. Natural history and treatment of chronic delta hepatitis. J Viral Hepat. 2010;17:749-56.